Latest filing published 20 Oct 2025 for BioRestorative Therapies, Inc., €21k. Read the official filing
Across 20 buy signals with a settled T+90 return. Return basis: close on the day after publication.
All filings by Lance Alstodt on record concern BioRestorative Therapies, Inc., in the capacity of chief executive. Over a trading history stretching from 16 November 2021 to 6 October 2025, the count stands at 36 filings.
On the market, this insider has only ever bought: 31 purchases, €91k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 5 share grants.
In size, the median ticket on the buying side is €2,058. On 19 out of 31 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
Most recently, on 20 October 2025, the filings show a share grant worth €21k in BioRestorative Therapies, Inc. The last insider purchase was made public on 18 September 2023, 1,126 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 36 declarations